logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

RICI HEALTH (01526) repurchased 25,000 shares on October 20 for HK$22,200.

date
18:36 20/10/2026
avatar
GMT Eight
RICI HEALTH (01526) announced that on October 20, 2026, the company repurchased 25,000 shares for HK$22,200, at a repurchase price of HK$0.865-0.91 per share.
RICI HEALTH (01526) announced that on October 20, 2026, the company repurchased 25,000 shares for HK$22,200, at a repurchase price of HK$0.865-0.91 per share.
Related Articles
HK Stock
COWELL (01415) repurchased 300,000 shares on October 20 for HK$6.6216 million.
HK Stock
JINXUN RESOURCE (03636) plans to engage in foreign exchange derivative businesses such as forward foreign exchange settlement and sales, and swaps.
JPMorgan Chase & Co. increases its stake in DINGDANG HEALTH (09886) by approximately 70.1008 million shares at HK$0.71 per share.
COWELL (01415) repurchased 300,000 shares on October 20 for HK$6.6216 million.
HK Stock
JINXUN RESOURCE (03636) plans to engage in foreign exchange derivative businesses such as forward foreign exchange settlement and sales, and swaps.
HK Stock
JPMorgan Chase & Co. increases its stake in DINGDANG HEALTH (09886) by approximately 70.1008 million shares at HK$0.71 per share.
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.